Prokaryotic Recombinant Protein Market

Prokaryotic recombinant proteins are proteins that are encrypted by genes (recombinant DNA) and cloned into the prokaryotic system (E. coli). The high specificity and low immunogenicity of prokaryotic recombinant proteins make them suitable for chronic therapy and several autoimmune diseases.
Prokaryotic Recombinant Protein Market contains market size and forecasts of Prokaryotic Recombinant Protein in global, including the following market information:
Global Prokaryotic Recombinant Protein Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Prokaryotic Recombinant Protein Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Prokaryotic Recombinant Protein companies in 2021 (%)
The global Prokaryotic Recombinant Protein market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hormones Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prokaryotic Recombinant Protein include Eli Lilly and Company, Merck, Roche, Prospec-Tany Technogene, Cusabio Technology, Randox Laboratories, Batavia Biosciences, Geno Technology and Kaneka and Eurogentec, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prokaryotic Recombinant Protein manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prokaryotic Recombinant Protein Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Prokaryotic Recombinant Protein Market Segment Percentages, by Type, 2021 (%)
Hormones
Interferons
Interleukins
Others
Global Prokaryotic Recombinant Protein Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Prokaryotic Recombinant Protein Market Segment Percentages, by Application, 2021 (%)
Biotechnology Companies
Research institutes
Contract Research organizations
Hospital
Laboratories
Others
Global Prokaryotic Recombinant Protein Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Prokaryotic Recombinant Protein Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prokaryotic Recombinant Protein revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Prokaryotic Recombinant Protein revenues share in global market, 2021 (%)
Key companies Prokaryotic Recombinant Protein sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Prokaryotic Recombinant Protein sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly and Company
Merck
Roche
Prospec-Tany Technogene
Cusabio Technology
Randox Laboratories
Batavia Biosciences
Geno Technology
Kaneka and Eurogentec
Abnova Corporation
Cayman Chemical Company
Geltor IndieBio
Bioclone